Philip Shirk

546 total citations · 1 hit paper
2 papers, 86 citations indexed

About

Philip Shirk is a scholar working on Infectious Diseases, Epidemiology and Organic Chemistry. According to data from OpenAlex, Philip Shirk has authored 2 papers receiving a total of 86 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 1 paper in Epidemiology and 0 papers in Organic Chemistry. Recurrent topics in Philip Shirk's work include Viral gastroenteritis research and epidemiology (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and SARS-CoV-2 detection and testing (1 paper). Philip Shirk is often cited by papers focused on Viral gastroenteritis research and epidemiology (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and SARS-CoV-2 detection and testing (1 paper). Philip Shirk collaborates with scholars based in United States. Philip Shirk's co-authors include Anastasia S. Lambrou, Benjamin J. Silk, Clinton R. Paden, Zachary Smith, Joseph D. Miller, Ruth Link‐Gelles, Allison Avrich Ciesla, Josephine Mak, Amadea Britton and Katherine E. Fleming-Dutra and has published in prestigious journals such as MMWR Morbidity and Mortality Weekly Report.

In The Last Decade

Philip Shirk

2 papers receiving 83 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024

2024 80 citations Ruth Link‐Gelles, Allison Avrich Ciesla et al. MMWR Morbidity and Mortality Weekly Report profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip Shirk United States	2	74	31	17	15	10	2	86
Jade King United Kingdom	5	102 1.4×	41 1.3×	30 1.8×	9 0.6×	7 0.7×	6	120
David Adegbite United Kingdom	4	98 1.3×	40 1.3×	30 1.8×	6 0.4×	7 0.7×	4	112
Rachel Blacow United Kingdom	3	116 1.6×	17 0.5×	13 0.8×	21 1.4×	23 2.3×	3	153
Mike Mannell United States	3	91 1.2×	16 0.5×	27 1.6×	10 0.7×	4 0.4×	4	122
Ginger Stringer United States	4	63 0.9×	15 0.5×	16 0.9×	6 0.4×	7 0.7×	5	77
Bashir Aden United Arab Emirates	5	54 0.7×	25 0.8×	13 0.8×	5 0.3×	4 0.4×	6	80
Sophie J. Prosolek United Kingdom	2	69 0.9×	12 0.4×	34 2.0×	12 0.8×	8 0.8×	2	88
Nicolás Kreplak Argentina	5	97 1.3×	49 1.6×	14 0.8×	7 0.5×	3 0.3×	12	110
Mustafizur Rahman Bangladesh	5	88 1.2×	22 0.7×	34 2.0×	9 0.6×	4 0.4×	9	115
Anna Kocharian United States	5	60 0.8×	15 0.5×	24 1.4×	33 2.2×	2 0.2×	5	108

Countries citing papers authored by Philip Shirk

Since Specialization

Citations

This map shows the geographic impact of Philip Shirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Shirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Shirk more than expected).

Fields of papers citing papers by Philip Shirk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Shirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Shirk. The network helps show where Philip Shirk may publish in the future.

Co-authorship network of co-authors of Philip Shirk

This figure shows the co-authorship network connecting the top 25 collaborators of Philip Shirk. A scholar is included among the top collaborators of Philip Shirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip Shirk. Philip Shirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

2 of 2 papers shown

1.

Link‐Gelles, Ruth, Allison Avrich Ciesla, Josephine Mak, et al.. (2024). Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024. MMWR Morbidity and Mortality Weekly Report. 73(4). 77–83. 80 indexed citations breakdown →

2.

Scobie, Heather M., Akilah R. Ali, Philip Shirk, et al.. (2023). Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants — United States, November 2021–January 2023. MMWR Morbidity and Mortality Weekly Report. 72(5). 125–127. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact